To clarify relationships between serum thyroid-stimulating hormone (TSH) levels and ultrastructural changes in thyrotrophs caused by intermittent or continuous treatments with antithyroid compound, male Fischer-344 rats initiated with N-bis(2-hydroxypropyl)nitrosamine (DHPN) were given water containing 0.1% sulfadimethoxine (SM) for 8 wk and then sacrificed (Group 1). Additional groups were examined 2 wk after withdrawal (Group 2), after 4 wk retreatment following a 2-wk withdrawal period (Group 3), and after 14 wk continuous exposure (Group 4). Control rats (Group 5) remained untreated for 8 wk after the DHPN initiation. Microscopic examination revealed hypertrophy of thyrotrophs and depletion of TSH-positive material in Groups 1, 3, and 4 but a return to normal in Group 2. Electron microscopic examination of thyrotrophs in the anterior pituitary in Groups 1, 3, and 4 revealed dilated rough endoplasmic reticulum (ER) cisternae with intracisternal dense granules as well as diminished numbers of intracytoplasmic secretory granules, these changes being most marked in Group 1 and least pronounced in Group 4. The number of intracytoplasmic secretory granules in Group 3 was much lower than in Group 4, as demonstrated by morphometric analysis. In Group 2, thyrotrophs showed dilated rough ER cisternae without intracisternal dense granules and essentially the same component of intracytoplasmic secretory granules as Group 5. The present study suggests that while prolonged continuous treatment with SM results in gradual acclimation to an increased demand for TSH, intermittent treatment elicits a persistent state of reduced TSH storage in thyrotrophs due to a continued strong feedback through the hypothalamus-pituitary-thyroid axis.
INTRODUCTION
Although it is well established that the pituitary gland secretes the thyroid-stimulating hormone (TSH), which regulates the function of the thyroid and can promote tumorigenesis from thyrotrophs, comparative morphological studies at the ultrastructural level have been limited.
Because Hiasa et al (7) first reported an effective rat thyroid 2-stage carcinogenesis model in 1982, it has been utilized by many investigators in extensive studies on the influence of a variety of antithyroid compounds (9, 10, 15, 21, 26, 27) . These treatments cause decreased T3/T4 levels in the blood due to disruption of thyroid function, followed by increased TSH levels via the negative feedback mechanism of the thyroid-pituitary axis (6, 8) . Several investigators have conducted electron microscopic studies of the mode of TSH secretion from thyrotrophs of the pituitary in thyroidectomized (4, 5, 11, 13, 22) or sulfonamide-treated (18) animals and demonstrated that the thyrotrophs in these cases are characterized by dilated cistemae of rough endoplasmic reticulum (ER) with intracistemal dense granules. With sulfonamide (18) , the treatment period was relatively short, at 30 days, and it is unclear how thyrotrophs respond to decreased thyroid hormone levels when goitrogens are administered over a long period. Furthermore, relationships between ultrastructural changes of thyrotrophs and kinetics of blood T3, T4, or TSH levels, in relation to 2-stage thyroid carcinogenesis in the rat have not been detailed. A timecourse experiment with sulfadimethoxine (SM) earlier demonstrated that serum TSH levels are elevated from week 1 and reach a peak at week 8, until gradual decrease thereafter (15) . Intermittent SM treatment resulted, however, in a secondary increase after withdrawal (27) . Given these findings, a clarification of how the hormonal regulation system works under such conditions is necessary.
We therefore performed the present intermittent treatment experiment in which N-bis(2-hydroxypropyl)nitrosamine (DHPN)-initiated rats received a long- acting antimicrobial that inhibits thyroid peroxidase (2, 17, 25) and SM and examined ultrastructural changes of thyrotrophs in the pituitary in relation to thyroid hormone levels.
MATERIALS AND METHODS
Animals. Male Fischer-344 rats, 4 wk old, were obtained from Charles River Japan Inc. (Shiga, Japan) and housed at a maximum of 5 per polycarbonated cage with white chips as bedding in an air-conditioned animal room (room temperature 24 ± 3°C, relative humidity 60 ± 10%, 12 with vesiculation in Group 1 (A) among treated groups. There were no differences in the severity between Groups 3 (B) and 4 (C). H&E. -Ultrastructural morphology of a thyrotroph from the pituitary of a control rat. The thyrotroph has polyhedral shape and small secretory granules (SG) (100-150 nm in diameter) in the cytoplasm, which are particularly numerous along the cell membrane. Note the normal appearance of the elements of rough ER (rER). Bar = 1 ~.m. into 5 equal groups. All rats received a single subcutaneous injection of 2,800 mg/kg DHPN at the commencement, and starting 1 wk thereafter those in Group 1 were given water containing 0.1 % SM for 8 wk. The animals in Group 2 received the same treatment followed by 2 wk without supplement. Group 3 received water containing 0.1 % SM for the first 8 wk followed by a 2-wk withdrawal period and 4 wk retreatment, whereas rats in Group 4 were administered the compound continuously for 14 wk. The control group, Group 5, received basal diet and water throughout 8 Histopathologic and Morphometric Examination. All animals were autopsied and their pituitary weights were recorded. Portions of 3 anterior pituitaries each from Groups 1-5 were fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer followed by postfixing in 1 % osmic acid in the same buffer and embedding in Epon 812. Tissue samples were cut with an ultramicrotome and stained with uranyl acetate and lead citrate for electron microscopic examination using a JEM-1200 EX II electron microscope. Pituitary tissues were fixed in 10% neutral-buffered formalin, embedded in paraffin, sectioned at 4-5 jjbm, and stained with hematoxylin and eosin for light microscopic examination. In addition, immunohistochemical staining using a monoclonal TSH antibody, generously provided by the Hormone Center of Gunma University (Maebashi, Japan), was performed at a dilution of 1:10,000. DAKO ABC kits (DAKO, Glostrup, Denmark) were applied for performance of ABC immunohistochemistry with 3,3'-diaminobenzidine as the chromogen and hematoxylin for counterstaining. Morphological changes of thyrotrophs were classified into hypertrophy of thyrotrophs with vesiculation, increased number of thyrotrophs, and decreased TSH-positive materials in thyrotrophs and were graded according to the following criteria. Hypertrophy of thyrotrophs with vesiculation was graded as mild, moderate, and severe when the ratio of area of the hypertrophied cell per total areas of anterior pituitaries was up to 15, 15-30, and more than 30, respectively. Increased number of thyrotrophs was graded as mild and moderate when the number of thyrotrophs increased up to 1.5 and 1.5-3 times, respectively, as compared to the controls. Decreased Statistical Analysis. Data for body and pituitary weights and thyroid-relating hormone levels and morphometric data were used to generate mean and standard deviation values, and intergroup differences were then analyzed with the Student's t-test. The body and pituitary weight data were compared between the matched groups of age.
RESULTS

J Body and Pituitary Weight '
The body weight in Group 1 was significantly decreased as compared to that of Group 5, while the relative pituitary weight in Group 1 was significantly increased (Table I ). There were no significant differences in the body weights and absolute and relative weights of the pituitary between Groups 3 and 4.
Hormone Assay
Data for hormone levels in the serum are summarized in Fig. 1 . T3 levels were 0.37 -i-0.06, 0.68 ± 0.02, 0.33 ± 0.13, 0.27 ± 0.13, and 0.69 ± 0.11 ng/ml in Groups 1-5, respectively, significant decreases being seen in all but Group 2. There was no difference in serum T3 level between groups 3 and 4. Average serum T4 levels were 17.2 ± 2.4, 62.9 ± 5.2, 24.3 ± 2.7, 24.5 ± 2.1, and 41.2 ± 3.5 ng/ml in Groups 1-5, respectively, with that in Group 2 being significantly higher than the control value and those in the other groups being significantly decreased, and serum TSH levels were significantly increased at 91.5 ± 34.5, 56.0 ± 13.0, and 58.4 ± 17.1 ng/ml as compared to the control value of 13.9 ± 4.8 ng/ml in Groups 1, 3, and 4, respectively. That in Group 2 (9.5 ± 1.2 ng/ml) was within the normal range. Values for Groups 3 and 4 were almost the same and slightly lower than that for Group 1.
Microscopic Examination
Microscopic examination revealed hypertrophy of thyrotrophs with vesicular cytoplasm in Groups [1] [2] [3] [4] (Figs.  2 and 3) , and the quantity of TSH-positive material in the cytoplasm was moderately decreased in Groups 1 and 3 and slightly down in Group 4 as compared to Group 5 (Figs. 2 and 4 ). The quantity of TSH-positive material in Group 2 (Fig. 4 ) was similar to that in the untreated group. In addition, increase in the number of thyrotrophs in the pituitary was seen in rats from Groups 1, 3, and 4, being especially remarkable in Group 1.
Electron Microscopic and
Morphometric Examination
The thyrotrophs in the untreated group, as shown by previous investigations (4, 11) , had a polyhedral outline and small spherical secretory granules (100-150 nm in diameter) that have been proven to contain TSH immunologically (22, 23) . Intracytoplasmic secretory granules were located along the cell surface and were relatively few in number as compared to the other anterior pituitary cells (4, 11) (Fig. 5 ). Those in Groups 1, 3, and 4 were characterized by dilated rough ER cisternae containing homogenous colloidlike fluid with electron-dense granules (Figs. [6] [7] [8] . These changes were most remarkable in Group 1, with granules varying considerably in size. Thyrotrophs in Group 2 exhibited dilated rough ER cisternae without dense granules. In contrast, secretory granules in the cytoplasm were diminished in number in Groups 1, 3, and 4 as compared to Group 5 and prominently so in Groups 1 and 3. The number in Group 3 was much lower than in Group 4. Numbers in Group 2 appeared to be greater than in Group 5. Results of morphometric analysis of intracytoplasmic secretory granules are shown in Table II . The number of intracytoplasmic secretory granules was significantly decreased in Groups 1 and 3 as compared to Group 5. In comparison of Groups 3 and 4, the number of secretory granules in Group 3 was significantly lower than in Group 4. The number in Group 2 was increased compared to that in Group 5, the value attaining a statistical significance.
DISCUSSION
In the present study, serum T4 levels in the 8-wk continuous group were more clearly decreased than in the 14-wk continuous treatment group; consequently, serum TSH was elevated more remarkably. These findings are in good agreement with the results of a time-course experiment with SM, which showed the serum TSH level to be highest at week 8 (15) . Although the return of TSH level after 2 wk recovery to normal range in line with the rapid increase of serum T4 was followed by reelevation with further treatment, the value attained was not as high as that seen after 8 wk. Similar changes in TSH level, which after retreatment was elevated up to the level before withdrawal of treatment, were reported by Wynford-Thomas et al (30) in an experiment where aminotriazole was chronically administered to rats. The outcomes obtained in these 2 experiments indicate that the antithyroidal effects of aminotriazole are more potent than those of SM. In the present case, there were no differences in serum levels of T3, T4, and TSH between the intermittent and 14-wk continuous-treatment groups, suggesting a lack of any difference in inhibitory effects on thyroid hormone synthesis between these treatments. The ratio of release of TSH from the pituitary is delicately controlled by the amount of the circulating levels of T3 and T4 (6, 8, 24) : Circulating T4 is all derived from the thyroid, whereas only 20% of T3 is synthesized there, the remaining 80% being generated by conversion of T4 primarily in the liver, kidney, and pituitary (8) . The quantity of TSH messenger RNA synthesized in thyrotrophs is known to be regulated by binding of T3 to the T3 nuclear receptor, with a negative correlation to the occupancy rate (3, 28, 29) . In kinetic studies of euthyroid rats, only 40-SO% of nuclear T3 in the pituitary proved to be derived from circulating T3, with conversion from T4 within pituitary tissues accounting for the remainder (1). Therefore, thyrotrophs are able to respond sensitively to decreased serum T4 and secrete excess TSH (1, 14) . The results of the present study using a 2-stage carcinogenesis model are consistent with hormonal regulation system via this negative feedback mechanism.
Microscopic findings in both continuous and intermittent groups suggested a hyperfunctional state of the thyrotroph in response to TSH stimulation. Similar morphological findings were described for experiments in which other antithyroid compounds were administered to rodents (16, 19, 20) . Electron microscopic examination in the 8-wk continuous-treatment group revealed alterations of the TSH production system. It has been described that TSH is synthesized and secreted in the thyrotroph through the following process: the synthesis of proteins in the rough ER, production of granules in the cistemae of the Golgi complex, and storage in the cytoplasm before discharge by exocytosis (4) . Our findings would suggest striking synthetic and secretory activity. Similar changes were also seen in the intermittent and 14-wk continuous-treatment groups, albeit to a lesser extent, than in the 8-wk treatment group. Such ultrastructural changes are essentially identical to those following thyroidectomy (4, 5, 11, 13, 22) and goitrogen treatment (18) , whereby secretory substance rapidly synthesized in the rough ER is retained as colloid fluid that condenses in dilated ER elements to generate intracistemal dense granules (4, 11) . Such granules have been demonstrated immunohistochemically to contain TSH (12, 22) . In the recovery group (Group 2), the rough ER was dilated without intracisternal dense granules, but the number of intracytoplasmic secretory granules was increased com- pared to that in the control group (Group 5), suggesting that the synthesis of TSH correlates reversely with storage of secretory granules in the cytoplasm.
Comparison of the ultrastructural appearance of thyrotrophs in the intermittent and 14-wk continuous-treatment groups revealed a difference, despite the lack of any difference in circulating TSH levels between the 2 groups. The number of intracytoplasmic secretory granules indicative of TSH-releasing activity was more decreased in intermittent treatment than continuous treatment, although there was no apparent difference in the rough ER dilation with intracistemal granules indicative of TSH synthetic activity between these treatments. Morphological changes of the rough ER are considered to be in support of the theory that TSH synthesis in the thyrotroph is delicately controlled by levels of circulating thyroid hormones (6, 8, 24) , taking into account the fact that there were no differences in circulating T3 and T4 levels between both groups. Why there were no differences in circulating TSH levels between these 2 groups despite differences in their releasing activity of secretory granules, remains unknown. Retreatment after cessation of treatment causes moderately decreased accumulation of secretory granules in the cytoplasm because of rapid discharge of TSH into the blood (4, 11) . In a previous intermittent treatment experiment with 2 cycles of 2 wk recovery and 4 wk retreatment after an initial 8-wk treatment with SM, we demonstrated that intracytoplasmic secretory granules were moderately decreased (27) . The fact that their number approached the normal state after 14 wk continuous treatment probably indicates an acclimation to an increased demand for TSH. Thyrotropinreleasing hormone (TRH) from the hypothalamus is known to govern TSH secretion from the thyrotroph (6, 8, 24) . The speculation is that TRH binds to plasma membrane receptors resulting in activation of adenylate cyclase. Subsequent accumulation of cyclic adenosine monophosphate in thyrotrophs causes an inflow of calcium ions that leads to contraction of microfilaments and peripheral movement and discharge of TSH-containing secretion granules into pituitary capillaries (8) . TRH may be involved in the secretory process of TSH granules differently in intermittent treatment compared to 14 wk continuous treatment, and the intermittent treatment may elicit rapid secretory-type TSH control due to a prominent feedback mechanism through the hypothalamus-pituitary-thyroid axis.
